Literature DB >> 2026889

Seasonal variation of Legionnaires' disease in Scotland.

R S Bhopal1, R J Fallon.   

Abstract

A summer and autumn peak in incidence is a characteristic epidemiological feature of Legionnaires' disease, a fact which may help in diagnosis. Previous reports from Scotland have reported a winter peak. This study examined the seasonal variation in Legionnaires' disease in Scotland in each year and by category of diagnosis. A characteristic summer/autumn peak was seen for travel-related infection. For non-travel infection, there was an autumnal peak between 1978 and 1982 but an early winter peak between 1983 and 1986. Overall, the pattern could be described as a summer/autumn plateau reaching a peak in early winter. This pattern, seen in men and women, was clearest in the Greater Glasgow area. Nosocomial cases were clustered in the months of October, November and December. In non-travel cases the classical seasonal pattern was not observed and clinicians cannot rely upon this epidemiological feature for diagnosis. However, the relative infrequency of the disease between January and May was a consistent and potentially useful feature. Most reports on seasonal variation are based on aggregated data on travel and non-travel cases. The present observations question the hypotheses developed to explain the seasonal pattern and call for further studies.

Entities:  

Mesh:

Year:  1991        PMID: 2026889     DOI: 10.1016/0163-4453(91)91569-j

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

1.  Going with the flow: legionellosis risk in Toronto, Canada is strongly associated with local watershed hydrology.

Authors:  Victoria Ng; Patrick Tang; Frances Jamieson; Steven J Drews; Shirley Brown; Donald E Low; Caroline C Johnson; David N Fisman
Journal:  Ecohealth       Date:  2009-04-16       Impact factor: 3.184

2.  Pinpointing clusters of apparently sporadic cases of Legionnaires' disease.

Authors:  R S Bhopal; P Diggle; B Rowlingson
Journal:  BMJ       Date:  1992-04-18

3.  A model for autumn outbreaks of Legionnaires' disease associated with cooling towers, linked to system operation and size.

Authors:  R H Bentham; C R Broadbent
Journal:  Epidemiol Infect       Date:  1993-10       Impact factor: 2.451

4.  Nosocomial Legionnaires' disease in England and Wales, 1980-92.

Authors:  C A Joseph; J M Watson; T G Harrison; C L Bartlett
Journal:  Epidemiol Infect       Date:  1994-04       Impact factor: 2.451

5.  Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.

Authors:  H K Johansen; N Høiby
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

6.  Pityriasis rosea Gibert: detection of Legionella micdadei antibodies in patients.

Authors:  I Gjenero-Margan; R Vidovic; V Drazenovic
Journal:  Eur J Epidemiol       Date:  1995-08       Impact factor: 8.082

7.  Dynamics of Legionella spp. and bacterial populations during the proliferation of L. pneumophila in a cooling tower facility.

Authors:  Nathalie Wéry; Valérie Bru-Adan; Céline Minervini; Jean-Philippe Delgénes; Laurent Garrelly; Jean-Jacques Godon
Journal:  Appl Environ Microbiol       Date:  2008-04-04       Impact factor: 4.792

8.  Atypical presentation of Legionella pneumonia among patients with underlying cancer: A fifteen-year review.

Authors:  Maria del Castillo; Anabella Lucca; Andrew Plodkowski; Yao-Ting Huang; Janice Kaplan; Kathleen Gilhuley; N Esther Babady; Susan K Seo; Mini Kamboj
Journal:  J Infect       Date:  2015-10-20       Impact factor: 6.072

Review 9.  Outbreaks of Legionnaires' Disease and Pontiac Fever 2006-2017.

Authors:  K A Hamilton; A J Prussin; W Ahmed; C N Haas
Journal:  Curr Environ Health Rep       Date:  2018-06

10.  Meteorological factors and risk of community-acquired Legionnaires' disease in Switzerland: an epidemiological study.

Authors:  Lisa Conza; Simona Casati; Costanzo Limoni; Valeria Gaia
Journal:  BMJ Open       Date:  2013-03-05       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.